Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries.
Journal
Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015
Informations de publication
Date de publication:
26 Jan 2024
26 Jan 2024
Historique:
received:
19
04
2023
accepted:
15
12
2023
medline:
27
1
2024
pubmed:
27
1
2024
entrez:
26
1
2024
Statut:
aheadofprint
Résumé
Improving hypertension control in low- and middle-income countries has uncertain implications across socioeconomic groups. In this study, we simulated improvements in the hypertension care cascade and evaluated the distributional benefits across wealth quintiles in 44 low- and middle-income countries using individual-level data from nationally representative, cross-sectional surveys. We raised diagnosis (diagnosis scenario) and treatment (treatment scenario) levels for all wealth quintiles to match the best-performing country quintile and estimated the change in 10-year cardiovascular disease (CVD) risk of individuals initiated on treatment. We observed greater health benefits among bottom wealth quintiles in middle-income countries and in countries with larger baseline disparities in hypertension management. Lower-middle-income countries would see the greatest absolute benefits among the bottom quintiles under the treatment scenario (29.1 CVD cases averted per 1,000 people living with hypertension in the bottom quintile (Q1) versus 17.2 in the top quintile (Q5)), and the proportion of total CVD cases averted would be largest among the lowest quintiles in upper-middle-income countries under both diagnosis (32.0% of averted cases in Q1 versus 11.9% in Q5) and treatment (29.7% of averted cases in Q1 versus 14.0% in Q5) scenarios. Targeted improvements in hypertension diagnosis and treatment could substantially reduce socioeconomic-based inequalities in CVD burden in low- and middle-income countries.
Identifiants
pubmed: 38278990
doi: 10.1038/s41591-023-02769-8
pii: 10.1038/s41591-023-02769-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982–3021 (2020).
pubmed: 33309175
pmcid: 7755038
doi: 10.1016/j.jacc.2020.11.010
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 389, 37–55 (2017).
pmcid: 5220163
doi: 10.1016/S0140-6736(16)31919-5
Sudharsanan, N. & Geldsetzer, P. Impact of coming demographic changes on the number of adults in need of care for hypertension in Brazil, China, India, Indonesia, Mexico, and South Africa. Hypertension 73, 770–776 (2019).
pubmed: 30739534
doi: 10.1161/HYPERTENSIONAHA.118.12337
Prabhakaran, D. et al. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. Lancet 391, 1224–1236 (2018).
pubmed: 29108723
doi: 10.1016/S0140-6736(17)32471-6
Samb, B. et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 376, 1785–1797 (2010).
pubmed: 21074253
doi: 10.1016/S0140-6736(10)61353-0
Beaglehole, R. et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet 372, 940–949 (2008).
pubmed: 18790317
doi: 10.1016/S0140-6736(08)61404-X
Kruk, M. E., Nigenda, G. & Knaul, F. M. Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am. J. Public Health 105, 431–437 (2015).
pubmed: 25602898
pmcid: 4330840
doi: 10.2105/AJPH.2014.302392
Chow, C. K. et al. Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob. Health 5, e002640 (2020).
pubmed: 33148540
pmcid: 7640501
doi: 10.1136/bmjgh-2020-002640
Attaei, M. W. et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health 2, e411–e419 (2017).
pubmed: 29253412
doi: 10.1016/S2468-2667(17)30141-X
Geldsetzer, P. et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet 394, 652–662 (2019).
pubmed: 31327566
doi: 10.1016/S0140-6736(19)30955-9
Manne-Goehler, J. et al. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. 16, e1002751 (2019).
pubmed: 30822339
pmcid: 6396901
doi: 10.1371/journal.pmed.1002751
Marcus, M. E. et al. Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. 18, e1003841 (2021).
pubmed: 34695124
pmcid: 8575312
doi: 10.1371/journal.pmed.1003841
Flood, D. et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev. 2, e340–e351 (2021).
pubmed: 35211689
pmcid: 8865379
doi: 10.1016/S2666-7568(21)00089-1
Martinez, R. et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study. Lancet Glob. Health 8, e511–e523 (2020).
pubmed: 32199120
doi: 10.1016/S2214-109X(20)30035-8
Kruk, M. E. et al. Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. Lancet 392, 2203–2212 (2018).
pubmed: 30195398
pmcid: 6238021
doi: 10.1016/S0140-6736(18)31668-4
Jan, S. et al. Action to address the household economic burden of non-communicable diseases. Lancet 391, 2047–2058 (2018).
pubmed: 29627161
doi: 10.1016/S0140-6736(18)30323-4
Hessel, P., Rodríguez-Lesmes, P. & Torres, D. Socio-economic inequalities in high blood pressure and additional risk factors for cardiovascular disease among older individuals in Colombia: results from a nationally representative study. PLoS ONE 15, e0234326 (2020).
pubmed: 32516351
pmcid: 7282633
doi: 10.1371/journal.pone.0234326
Peiris, D. et al. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level survey data. PLoS Med. 18, e1003485 (2021).
pubmed: 33661979
pmcid: 7932723
doi: 10.1371/journal.pmed.1003485
Malta, D. C. et al. Inequalities in health care and access to health services among adults with self-reported arterial hypertension: Brazilian National Health Survey. Cad. Saude Publica 38, e00125421 (2022).
doi: 10.1590/0102-311xe00125421
Joshi, S. & Thapa, B. B. Socioeconomic risk factors of hypertension and blood pressure among persons aged 15–49 in Nepal: a cross-sectional study. BMJ Open 12, e057383 (2022).
pubmed: 35649602
pmcid: 9161073
doi: 10.1136/bmjopen-2021-057383
Gatimu, S. M. & John, T. W. Socioeconomic inequalities in hypertension in Kenya: a decomposition analysis of 2015 Kenya STEPwise survey on non-communicable diseases risk factors. Int. J. Equity Health 19, 213 (2020).
pubmed: 33267846
pmcid: 7709247
doi: 10.1186/s12939-020-01321-1
Yang, F., Qian, D., Liu, X., Healthy Aging and Development Study Group in Nanjing Medical University & Data Mining Group of Biomedical Big Data in Nanjing Medical University. Socioeconomic disparities in prevalence, awareness, treatment, and control of hypertension over the life course in China. Int. J. Equity Health 16, 100 (2017).
pubmed: 28610576
pmcid: 5470255
doi: 10.1186/s12939-017-0597-8
Jung, L. et al. The interaction between district-level development and individual-level socioeconomic gradients of cardiovascular disease risk factors in India: a cross-sectional study of 2.4 million adults. Soc. Sci. Med. 239, 112514 (2019).
pubmed: 31541939
doi: 10.1016/j.socscimed.2019.112514
Haider, M. R. & Gupta, R. D. Inequalities in undiagnosed hypertension among adult population in Bangladesh: evidence from a nationally representative survey. High. Blood Press. Cardiovasc. Prev. 29, 57–64 (2022).
pubmed: 34757583
doi: 10.1007/s40292-021-00488-0
Adisasmito, W., Amir, V., Atin, A., Megraini, A. & Kusuma, D. Geographic and socioeconomic disparity in cardiovascular risk factors in Indonesia: analysis of the Basic Health Research 2018. BMC Public Health 20, 1004 (2020).
pubmed: 32586296
pmcid: 7318418
doi: 10.1186/s12889-020-09099-1
Sommer, I. et al. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health 15, 914 (2015).
pubmed: 26385563
pmcid: 4575459
doi: 10.1186/s12889-015-2227-y
Adjaye-Gbewonyo, K., Kawachi, I., Subramanian, S. V. & Avendano, M. Income inequality and cardiovascular disease risk factors in a highly unequal country: a fixed-effects analysis from South Africa. Int. J. Equity Health 17, 31 (2018).
pubmed: 29510733
pmcid: 5839065
doi: 10.1186/s12939-018-0741-0
Marmot, M. & Allen, J. J. Social determinants of health equity. Am. J. Public Health 104, S517–S519 (2014).
pubmed: 25100411
pmcid: 4151898
doi: 10.2105/AJPH.2014.302200
Wagstaff, A. Poverty and health sector inequalities. Bull. World Health Organ. 80, 97–105 (2002).
pubmed: 11953787
pmcid: 2567730
Kreiner, C. T., Nielsen, T. H. & Serena, B. L. Role of income mobility for the measurement of inequality in life expectancy. Proc. Natl Acad. Sci. USA 115, 11754–11759 (2018).
pubmed: 30373814
pmcid: 6243245
doi: 10.1073/pnas.1811455115
Zimmerman, F. J. & Anderson, N. W. Trends in health equity in the United States by race/ethnicity, sex, and income, 1993–2017. JAMA Netw. Open 2, e196386 (2019).
pubmed: 31251377
pmcid: 6604079
doi: 10.1001/jamanetworkopen.2019.6386
Niessen, L. W. et al. Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda. Lancet 391, 2036–2046 (2018).
pubmed: 29627160
doi: 10.1016/S0140-6736(18)30482-3
Allen, L. et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob. Health 5, e277–e289 (2017).
pubmed: 28193397
pmcid: 5673683
doi: 10.1016/S2214-109X(17)30058-X
Ochmann, S. et al. Diagnostic testing for hypertension, diabetes, and hypercholesterolaemia in low-income and middle-income countries: a cross-sectional study of data for 994 185 individuals from 57 nationally representative surveys. Lancet Glob. Health 11, e1363–e1371 (2023).
pubmed: 37591584
pmcid: 10480389
doi: 10.1016/S2214-109X(23)00280-2
Mohanty, S. K. et al. Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: a nationally representative cross-sectional study. PLoS Med. 18, e1003740 (2021).
pubmed: 34428221
pmcid: 8425529
doi: 10.1371/journal.pmed.1003740
Ahmed, S., Tariqujjaman, M., Rahman, M. A., Hasan, M. Z. & Hasan, M. M. Inequalities in the prevalence of undiagnosed hypertension among Bangladeshi adults: evidence from a nationwide survey. Int. J. Equity Health 18, 33 (2019).
pubmed: 30770739
pmcid: 6377713
doi: 10.1186/s12939-019-0930-5
Antignac, M. et al. Socioeconomic status and hypertension control in Sub-Saharan Africa: the multination EIGHT study (Evaluation of Hypertension in Sub-Saharan Africa). Hypertension 71, 577–584 (2018).
pubmed: 29378852
doi: 10.1161/HYPERTENSIONAHA.117.10512
Murphy, A. et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. Lancet Glob. Health 6, e292–e301 (2018).
pubmed: 29433667
pmcid: 5905400
doi: 10.1016/S2214-109X(18)30031-7
Basu, S. & Millett, C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 62, 18–26 (2013).
pubmed: 23670299
doi: 10.1161/HYPERTENSIONAHA.113.01374
Jaacks, L. M. et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 7, 231–240 (2019).
pubmed: 30704950
pmcid: 7360432
doi: 10.1016/S2213-8587(19)30026-9
Popkin, B. M. The nutrition transition: an overview of world patterns of change. Nutr. Rev. 62, S140–S143 (2004).
pubmed: 15387480
doi: 10.1111/j.1753-4887.2004.tb00084.x
NCD Risk Factor Collaboration (NCD-RisC).Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature 569, 260–264 (2019).
pmcid: 6784868
doi: 10.1038/s41586-019-1171-x
Wetzel, S. et al. Changing socioeconomic and geographic gradients in cardiovascular disease risk factors among Indians aged 15–49 years – evidence from nationally representative household surveys. Lancet Reg. Health Southeast Asia. 12, 100188 (2023).
pubmed: 37384058
pmcid: 10305936
doi: 10.1016/j.lansea.2023.100188
World Health Organization. HEARTS: technical package for cardiovascular disease management in primary health care: risk-based CVD management. https://www.who.int/publications/i/item/9789240001367 (World Health Organization, 2020).
Haakenstad, A., Coates, M., Marx, A., Bukhman, G. & Verguet, S. Disaggregating catastrophic health expenditure by disease area: cross-country estimates based on the World Health Surveys. BMC Med. 17, 36 (2019).
pubmed: 30755209
pmcid: 6372998
doi: 10.1186/s12916-019-1266-0
Haakenstad, A., Coates, M., Bukhman, G., McConnell, M. & Verguet, S. Comparative health systems analysis of differences in the catastrophic health expenditure associated with non-communicable vs communicable diseases among adults in six countries. Health Policy Plan. 37, 1107–1115 (2022).
pubmed: 35819006
pmcid: 9557357
doi: 10.1093/heapol/czac053
Pesec, M. et al. Primary health care that works: the Costa Rican experience. Health Aff. (Millwood) 36, 531–538 (2017).
Seidman, G. & Atun, R. Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries. Hum. Resour. Health 15, 29 (2017).
pubmed: 28407810
pmcid: 5390445
doi: 10.1186/s12960-017-0200-9
Joshi, R. et al. Task shifting for non-communicable disease management in low and middle income countries—a systematic review. PLoS ONE 9, e103754 (2014).
pubmed: 25121789
pmcid: 4133198
doi: 10.1371/journal.pone.0103754
Husain, M. J. et al. Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application. BMJ Open 12, e061467 (2022).
pubmed: 35760540
pmcid: 9237880
doi: 10.1136/bmjopen-2022-061467
Ueda, P. et al. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diabetes Endocrinol. 5, 196–213 (2017).
pubmed: 28126460
pmcid: 5354360
doi: 10.1016/S2213-8587(17)30015-3
Nazarzadeh, M. et al. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis. Lancet Diabetes Endocrinol. 10, 645–654 (2022).
pubmed: 35878651
pmcid: 9622419
doi: 10.1016/S2213-8587(22)00172-3
Hajifathalian, K. et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 3, 339–355 (2015).
pubmed: 25819778
pmcid: 7615120
doi: 10.1016/S2213-8587(15)00081-9
WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob. Health 7, e1332–e1345 (2019).
doi: 10.1016/S2214-109X(19)30318-3
Mauer, N. et al. Longitudinal evidence on treatment discontinuation, adherence, and loss of hypertension control in four middle-income countries. Sci. Transl. Med. 14, eabi9522 (2022).
pubmed: 35857627
doi: 10.1126/scitranslmed.abi9522
Rubin, D. B. Inference and missing data. Biometrika 63, 581–592 (1976).
doi: 10.1093/biomet/63.3.581
Prioritarianism in Practice (eds. Adler, M. D. & Norheim, O. F.) (Cambridge Univ. Press, 2022).
World Bank. World Bank Country and Lending Groups. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
Manne-Goehler, J. et al. Data resource profile: the Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC). Int. J. Epidemiol. 51, e337–e349(2022).
pubmed: 35762972
doi: 10.1093/ije/dyac125
World Health Organization. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-resource Settings. https://www.who.int/publications/i/item/9789240009226 (World Health Organization, 2020).
Culyer, A. J. & Wagstaff, A. Equity and equality in health and health care. J. Health Econ. 12, 431–457 (1993).
pubmed: 10131755
doi: 10.1016/0167-6296(93)90004-X
Law, M. R., Morris, J. K. & Wald, N. J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338, b1665 (2009).
pubmed: 19454737
pmcid: 2684577
doi: 10.1136/bmj.b1665
Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2019 (GBD 2019) Data Resources. https://ghdx.healthdata.org/gbd-2019